 Pulmonary Surfactants
"Pulmonary Surfactants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI.
| Descriptor ID |
D011663
|
| MeSH Number(s) |
D27.505.954.796.600
|
| Concept/Terms |
Pulmonary Surfactants- Pulmonary Surfactants
- Surfactants, Pulmonary
- Pulmonary Surfactant
- Surfactant, Pulmonary
|
Below are MeSH descriptors whose meaning is more general than "Pulmonary Surfactants".
Below are MeSH descriptors whose meaning is more specific than "Pulmonary Surfactants".
This graph shows the total number of publications written about "Pulmonary Surfactants" by people in this website by year, and whether "Pulmonary Surfactants" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 2 | 0 | 2 | | 1992 | 2 | 0 | 2 | | 1993 | 2 | 0 | 2 | | 1994 | 4 | 1 | 5 | | 1995 | 3 | 2 | 5 | | 1996 | 0 | 2 | 2 | | 1997 | 2 | 1 | 3 | | 1998 | 1 | 0 | 1 | | 1999 | 0 | 1 | 1 | | 2000 | 2 | 3 | 5 | | 2001 | 0 | 1 | 1 | | 2002 | 4 | 1 | 5 | | 2003 | 2 | 0 | 2 | | 2004 | 2 | 1 | 3 | | 2006 | 0 | 1 | 1 | | 2007 | 1 | 3 | 4 | | 2009 | 1 | 3 | 4 | | 2010 | 1 | 2 | 3 | | 2011 | 2 | 0 | 2 | | 2012 | 2 | 1 | 3 | | 2013 | 4 | 1 | 5 | | 2015 | 2 | 0 | 2 | | 2016 | 1 | 2 | 3 | | 2017 | 0 | 2 | 2 | | 2018 | 1 | 3 | 4 | | 2019 | 0 | 3 | 3 | | 2020 | 0 | 2 | 2 | | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Pulmonary Surfactants" by people in Profiles.
-
Mandell E, Kinsella JP, Abman SH. Persistent pulmonary hypertension of the newborn. Pediatr Pulmonol. 2021 03; 56(3):661-669.
-
Schmidt AF, Kannan PS, Bridges J, Presicce P, Jackson CM, Miller LA, Kallapur SG, Chougnet CA, Jobe AH. Prenatal inflammation enhances antenatal corticosteroid-induced fetal lung maturation. JCI Insight. 2020 12 17; 5(24).
-
Dobrinskikh E, Al-Juboori SI, Oria M, Reisz JA, Zheng C, Peiro JL, Marwan AI. Heterogeneous Response in Rabbit Fetal Diaphragmatic Hernia Lungs After Tracheal Occlusion. J Surg Res. 2020 06; 250:23-38.
-
Numata M, Mitchell JR, Tipper JL, Brand JD, Trombley JE, Nagashima Y, Kandasamy P, Chu HW, Harrod KS, Voelker DR. Pulmonary surfactant lipids inhibit infections with the pandemic H1N1 influenza virus in several animal models. J Biol Chem. 2020 02 07; 295(6):1704-1715.
-
Correll KA, Edeen KE, Zemans RL, Redente EF, Serban KA, Curran-Everett D, Edelman BL, Mikels-Vigdal A, Mason RJ. Transitional human alveolar type II epithelial cells suppress extracellular matrix and growth factor gene expression in lung fibroblasts. . 2019 08 01; 317(2):L283-L294.
-
Davis JM, Pilon AL, Shenberger J, Breeze JL, Terrin N, Mazela J, Gulczynska E, Lauterbach R, Parad R. The role of recombinant human CC10 in the prevention of chronic pulmonary insufficiency of prematurity. Pediatr Res. 2019 08; 86(2):254-260.
-
Mandell EW, Kratimenos P, Abman SH, Steinhorn RH. Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia. Clin Perinatol. 2019 06; 46(2):291-310.
-
Dobrinskikh E, Al-Juboori SI, Shabeka U, Reisz JA, Zheng C, Marwan AI. Heterogeneous Pulmonary Response After Tracheal Occlusion: Clues to Fetal Lung Growth. J Surg Res. 2019 07; 239:242-252.
-
Voelker DR, Numata M. Phospholipid regulation of innate immunity and respiratory viral infection. J Biol Chem. 2019 03 22; 294(12):4282-4289.
-
Knudsen L, Lopez-Rodriguez E, Berndt L, Steffen L, Ruppert C, Bates JHT, Ochs M, Smith BJ. Alveolar Micromechanics in Bleomycin-induced Lung Injury. Am J Respir Cell Mol Biol. 2018 12; 59(6):757-769.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|